| Drug Class: |
Phosphodiesterase type 5 (PDE5) inhibitor; vasodilatory agent |
| Molecular Formula: |
C22H19N3O4 |
| Molecular Weight: |
389.40 g/mol |
| Form: |
Oral tablets |
| Purity: |
Pharmaceutical-grade active substance |
| Sequence: |
Not applicable (small-molecule compound) |
| Brand: |
Dragon Pharma |
| Substances: |
Tadalafil (commonly known as Cialis active ingredient) |
| Concentration: |
20 mg |
Product Disclaimer: Research Purposes Only
This product is intended strictly for laboratory research and in vitro analysis. It is not approved for human or animal use. Any form of internal administration is prohibited by law. Handling should be limited to qualified and licensed professionals. This item is not classified as a pharmaceutical, dietary supplement, or cosmetic product. For educational and scientific research use only.
What is Dragon Pharma Cialis?
Cialis (tadalafil) is an oral phosphodiesterase type 5 (PDE5) inhibitor used to manage erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It enhances erectile function by increasing blood flow to penile tissue in response to sexual stimulation. In research, Cialis is studied for its cardiovascular effects, smooth muscle relaxation, and potential roles in pulmonary hypertension and endothelial function, making it a valuable compound in urological and cardiovascular experimental models.
Mechanism of Action:
Cialis works by selectively inhibiting PDE5, an enzyme that degrades cyclic guanosine monophosphate (cGMP) in penile smooth muscle. By preventing cGMP breakdown, Cialis promotes relaxation of smooth muscle and vasodilation in the corpus cavernosum, enhancing blood flow and facilitating erection. Its prolonged half-life allows for flexible dosing schedules and sustained effect, providing a reliable model for studying vasodilatory mechanisms, sexual function, and nitric oxide-mediated pathways in experimental research.
Benefits:
- Improves erectile function and sexual performance in men with ED.
- Supports smooth muscle relaxation and vasodilation in the corpus cavernosum.
- May alleviate lower urinary tract symptoms in benign prostatic hyperplasia.
- Provides a research model for studying PDE5 inhibition and vascular function.
Research Applications:
- Investigating mechanisms of erectile dysfunction and vascular modulation.
- Exploring PDE5 inhibition in pulmonary hypertension and endothelial studies.
- Studying smooth muscle relaxation and nitric oxide-mediated signaling pathways.
- Researching combination therapies for urological and cardiovascular conditions.
Dosing Instructions:
- Dosing: Oral tablets, taken with or without food. Use consistent timing according to research protocol.
- Daily Dose: Typical research doses range from 5–20 mg, depending on study objectives.
- Route: Oral.
- Duration: Research studies may last from a few weeks to several months to assess efficacy and safety.
- Frequency: Once daily or as needed before sexual activity, depending on study design.
- Recommended Cycles: Continuous daily administration or intermittent dosing based on experimental goals.
- PCT: Not required; Cialis does not affect hormone levels directly.
Stacking With Other Products:
- L-Arginine for potential additive nitric oxide-mediated vasodilation.
- Pycnogenol or other antioxidants for enhanced endothelial function in studies.
- Viagra (Sildenafil) in experimental protocols to compare PDE5 inhibitor efficacy.
- Saw Palmetto or alpha-blockers for combined research in BPH symptom management.
Side Effects:
- Headache and flushing due to vasodilation.
- Dyspepsia or mild gastrointestinal discomfort.
- Nasal congestion or back pain in some cases.
- Rare visual disturbances or dizziness during high-dose studies.
Contraindications:
- Concurrent use with nitrates or nitric oxide donors due to risk of severe hypotension.
- Severe cardiovascular conditions including unstable angina or recent myocardial infarction.
- Hypersensitivity to Cialis or any excipients in the formulation.
- Severe hepatic or renal impairment without monitoring.
Conclusion
Cialis is a potent and long-acting PDE5 inhibitor widely used in research for erectile dysfunction, smooth muscle relaxation, and vascular studies. Its ability to enhance blood flow and support nitric oxide signaling makes it a key tool in urology and cardiovascular experimental models. Proper dosing, adherence to contraindications, and careful monitoring ensure safe and effective use in research settings. When combined with supportive agents like L-Arginine or antioxidants, Cialis can provide insights into synergistic effects on vascular and sexual health.
References:
- Andersson KE. "Pharmacology of PDE5 inhibitors in erectile dysfunction." British Journal of Pharmacology. 2004;143:1–18.
- Porst H, et al. "Tadalafil (Cialis) in the treatment of erectile dysfunction." Journal of Sexual Medicine. 2003;1:14–21.
- ClinicalTrials.gov Identifier: NCT00256699 – Tadalafil in erectile dysfunction studies.
- Galiè N, et al. "Tadalafil for the treatment of pulmonary arterial hypertension." New England Journal of Medicine. 2005;353:2148–2157.

Cialis FAQ
✔️ What is Cialis (Tadalafil)?
Cialis is a PDE5 inhibitor designed for research into vascular relaxation, blood flow, and erectile physiology in laboratory studies.
✔️ How does Cialis work?
It inhibits phosphodiesterase type-5 (PDE5), increasing cGMP levels in smooth muscle tissue, which enhances vasodilation and tissue perfusion for experimental applications.
✔️ What are the recommended storage conditions?
Store tablets in a cool, dry place at 15–30°C (59–86°F), away from direct sunlight, moisture, and heat. Keep them in the original packaging until use.
✔️ Is Cialis safe for laboratory research?
Yes, when handled under controlled experimental protocols, it is safe for preclinical and analytical studies. It is not for human consumption.
✔️ Can Cialis be combined with other compounds?
Yes, it can be studied alongside other PDE5 inhibitors, vasodilators, or peptides to investigate synergistic effects on vascular function and hemodynamics.
✔️ How long is Cialis stable?
Properly stored tablets remain stable until the expiration date. Avoid crushing, splitting, or exposing them to humidity or extreme temperatures, which can reduce potency and reliability.
Storage and Safety – Cialis (Tadalafil)
Proper storage and handling of Dragon Pharma Cialis (Tadalafil) are essential to maintain its potency, stability, and effectiveness for research and experimental applications. Tablets should be stored in a cool, dry environment at 15–30°C (59–86°F), protected from direct sunlight, heat, and moisture, which can degrade the active ingredient and reduce its activity. Keep tablets in their original blister pack or container until use to prevent contamination.
Avoid crushing or splitting tablets unless required for research purposes, as this may affect dosage consistency and chemical stability. Handle the product with clean, dry hands or sterile tools, and store it in a controlled environment free from excessive humidity. Keep all tablets out of reach of children, pets, and unauthorized personnel.
Dispose of expired or unused tablets according to pharmaceutical waste regulations. Do not flush tablets down drains or discard in regular household trash. Proper storage and safety measures ensure that Cialis (Tadalafil) retains full effectiveness and reliability for controlled laboratory, analytical, or experimental research applications.